Millipore Sigma Vibrant Logo

116812 Adenosine 3ʹ,5ʹ-cyclic Monophosphate, 8-(4-Chlorophenylthio)-, Sodium Salt - CAS 93882-12-3 - Calbiochem

Cell-permeable cAMP analog that activates both protein kinase A and protein kinase G.

FDS (Fiches de données de sécurité), certificats d’analyse (CoA) et de qualité (CoQ), dossiers, brochures et autres documents disponibles.

Synonymes: Adenosine 3ʹ,5ʹ-cyclic Monophosphate, 8-(4-Chlorophenylthio)-, Sodium Salt

Primary Target: Protein kinase A and protein kinase G
View Products on Sigmaaldrich.com
116812
Voir les Prix & la Disponibilité

Aperçu

Replacement Information

Tableau de caractéristiques principal

CAS #Empirical Formula
93882-12-3C₁₆H₁₄ClN₅O₆PS · Na

Prix & Disponibilité

Référence DisponibilitéConditionnement Qté Prix Quantité
116812-10MG
Récupération des données relatives à la disponibilité...
—
Disponibilité limitée Disponibilité limitée
En stock 
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Pour le restant : Nous vous tiendrons informé
      Pour le restant : Nous vous tiendrons informé
      Nous vous tiendrons informé
      Contacter le Service Clients
      Contact Customer Service

      		 Ampoule plast. 10 mg
      Prix en cours de récupération
      Le prix n'a pas pu être récupéré
      La quantité minimale doit être un multiple de
      Maximum Quantity is
      À la validation de la commande Plus d'informations
      Vous avez sauvegardé ()
       
      —
      Demander le prix
      		 —
      Description
      OverviewCell-permeable cAMP analog that activates both protein kinase A and protein kinase G. Directly activates Epac, a Rap1 guanine-nucleotide exchange factor. Also acts as a potent inhibitor of cGMP-specific phosphodiesterase (IC50 = 900 nM). Inhibits cAMP-specific phosphodiesterase at much higher concentrations (IC50 = 25 µM).
      Catalogue Number116812
      Brand Family Calbiochem®
      SynonymsAdenosine 3ʹ,5ʹ-cyclic Monophosphate, 8-(4-Chlorophenylthio)-, Sodium Salt
      References
      Referencesde Rooij, J., et al. 1998. Nature. 396, 474.
      Kawasaki, H., et al. 1998. Science. 282, 2275.
      Moed, P.J., et al. 1993. Comp. Biochem. Physiol. 105A, 711.
      Connolly, B.J., et al. 1992. Biochem. Pharmacol. 44, 2303.
      Phillips, M.E., and Taylor, A. 1992. J. Physiol. 456, 591.
      Shipston, M.J., and Antoni, F.A. 1992. Endocrinology 130, 2213.
      Datta, R., et al. 1991. Blood 78, 83.
      Peters, D.J.M., et al. 1991. Proc. Natl. Acad. Sci. USA 88, 9219.
      Sandberg, M., et al. 1991. Biochem. J. 279, 521.
      Unterman, T.G., et al. 1991. Endocrinology 128, 2693.
      Xu, H., et al. 1989. Brain Res. 504, 36.
      Product Information
      CAS number93882-12-3
      ATP CompetitiveN
      FormWhite solid
      Hill FormulaC₁₆H₁₄ClN₅O₆PS · Na
      Chemical formulaC₁₆H₁₄ClN₅O₆PS · Na
      Hygroscopic Hygroscopic
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetProtein kinase A and protein kinase G
      Primary Target IC<sub>50</sub>900 nM against cGMP-specific phosphodiesterase
      Purity≥98% by HPLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage -20°C
      Hygroscopic Hygroscopic
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 1 month at -20°C
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Référence GTIN
      116812-10MG 04055977208238

      Documentation

      Required Licenses

      Title
      PRODUCTO REGULADO POR LA SECRETARÍA DE SALUD

      Adenosine 3ʹ,5ʹ-cyclic Monophosphate, 8-(4-Chlorophenylthio)-, Sodium Salt - CAS 93882-12-3 - Calbiochem FDS

      Titre

      Fiche de données de sécurité des matériaux (FDS) 

      Adenosine 3ʹ,5ʹ-cyclic Monophosphate, 8-(4-Chlorophenylthio)-, Sodium Salt - CAS 93882-12-3 - Calbiochem Certificats d'analyse

      TitreNuméro de lot
      116812

      Références bibliographiques

      Aperçu de la référence bibliographique
      de Rooij, J., et al. 1998. Nature. 396, 474.
      Kawasaki, H., et al. 1998. Science. 282, 2275.
      Moed, P.J., et al. 1993. Comp. Biochem. Physiol. 105A, 711.
      Connolly, B.J., et al. 1992. Biochem. Pharmacol. 44, 2303.
      Phillips, M.E., and Taylor, A. 1992. J. Physiol. 456, 591.
      Shipston, M.J., and Antoni, F.A. 1992. Endocrinology 130, 2213.
      Datta, R., et al. 1991. Blood 78, 83.
      Peters, D.J.M., et al. 1991. Proc. Natl. Acad. Sci. USA 88, 9219.
      Sandberg, M., et al. 1991. Biochem. J. 279, 521.
      Unterman, T.G., et al. 1991. Endocrinology 128, 2693.
      Xu, H., et al. 1989. Brain Res. 504, 36.
      Fiche technique

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision07-April-2008 RFH
      SynonymsAdenosine 3ʹ,5ʹ-cyclic Monophosphate, 8-(4-Chlorophenylthio)-, Sodium Salt
      DescriptionCell-permeable cAMP analog that activates both protein kinase A and protein kinase G. Induces the guanine-nucleotide-exchange factor activity of EGFI, also known as Epac (exchange protein directly activated by cAMP), and EGFII towards Rap1 both in vivo and in vitro. Also acts as a potent inhibitor of cGMP specific phosphodiesterase (IC50 = 900 nM). Also inhibits cAMP-specific phosphodiesterases at much higher concentrations (IC50 = 25 µM).
      FormWhite solid
      CAS number93882-12-3
      Chemical formulaC₁₆H₁₄ClN₅O₆PS · Na
      Structure formulaStructure formula
      Purity≥98% by HPLC
      SolubilityH₂O (10 mg/ml)
      Storage -20°C
      Hygroscopic
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 1 month at -20°C
      Toxicity Standard Handling
      Referencesde Rooij, J., et al. 1998. Nature. 396, 474.
      Kawasaki, H., et al. 1998. Science. 282, 2275.
      Moed, P.J., et al. 1993. Comp. Biochem. Physiol. 105A, 711.
      Connolly, B.J., et al. 1992. Biochem. Pharmacol. 44, 2303.
      Phillips, M.E., and Taylor, A. 1992. J. Physiol. 456, 591.
      Shipston, M.J., and Antoni, F.A. 1992. Endocrinology 130, 2213.
      Datta, R., et al. 1991. Blood 78, 83.
      Peters, D.J.M., et al. 1991. Proc. Natl. Acad. Sci. USA 88, 9219.
      Sandberg, M., et al. 1991. Biochem. J. 279, 521.
      Unterman, T.G., et al. 1991. Endocrinology 128, 2693.
      Xu, H., et al. 1989. Brain Res. 504, 36.